Johnson & Johnson 13D and 13G filings for Protagonist Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-01-11 1:00 pm Unchanged |
2022-12-31 | 13G | Protagonist Therapeutics, Inc. PTGX |
JOHNSON & JOHNSON JNJ |
2,449,183 4.980% |
0 (Unchanged) |
Filing |
| 2021-02-01 5:41 pm Unchanged |
2020-12-31 | 13G | Protagonist Therapeutics, Inc. PTGX |
JOHNSON & JOHNSON JNJ |
2,449,183 5.700% |
0 (Unchanged) |
Filing |